Santen Pharmaceutical Co Ltd (OTCPK:SNPHY)
$ 10.63 0.01 (0.09%) Market Cap: 3.71 Bil Enterprise Value: 3.70 Bil PE Ratio: 21.47 PB Ratio: 1.99 GF Score: 76/100

Q2 2020 Santen Pharmaceutical Co Ltd Earnings Presentation Transcript

Nov 07, 2019 / 04:00AM GMT
Release Date Price: $18.35 (+1.94%)

Nov 07, 2019 / 04:00AM GMT
Presentation
Nov 07, 2019 / 04:00AM GMT

=====================
Corporate Participants
=====================
* Kazuo Koshiji
Santen Pharmaceutical Co., Ltd. - Senior Corp. Officer of Corporate Administration, CFO and Head of Finance & Administration Division
* Naveed Shams
Santen Pharmaceutical Co., Ltd. - Senior Corporate Officer, Chief Scientific Officer and Head of Global Research & Development
* Satoshi Suzuki
Santen Pharmaceutical Co., Ltd. - Senior Corporate Officer, Head of Corporate Development Division & Head of China Business
* Shigeo Taniuchi
Santen Pharmaceutical Co., Ltd. - President, COO, Head of North America Business & Director

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot